asked my compounder where the API comes from. long silence.
503B. That is the whole post, but I will justify it. Everything else people worry about in c/t2dglp1 is downstream of it. Titration speed, reflux, the endless dose arguments — most of it resolves if you sort 503B out first, and almost nobody does. I say this having got it wrong for 11 months. My ApoB was the thing…
This is correct. The shortage list does expire and the rules change.
Not to be pedantic but telehealth and 503B are being used interchangeably and they are not interchangeable in real life.
This is correct. The shortage list does expire and the rules change.
the shortage list is temporary, it ends and compounding becomes illegal again
Strongly agree. API source transparency matters.
Moved states and the compounding landscape changed completely. Different rules, different pharmacies, different costs.